• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $POTX

    Global X Cannabis ETF

    Subscribe to $POTX
    $POTX

    The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cannabis Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are active in the cannabis industry (collectively, " Cannabis Companies"), as defined by Solactive AG, the provider of the underlying index ("index provider"). The fund is non-diversified.

    IPO Year: n/a

    Exchange: NASDAQ

    Recent Analyst Ratings for Global X Cannabis ETF

    DatePrice TargetRatingAnalyst
    See more ratings

    Global X Cannabis ETF Press Releases

    Fastest customizable press release news feed in the world

    View All

    Global X ETFs To Liquidate 19 ETFs

    NEW YORK, Jan. 19, 2024 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds, today announced the scheduled liquidation of the following ETFs (the "Funds"), based on an ongoing review process of its product lineup to ensure it meets the evolving needs of its clients. The Funds scheduled for liquidation include: Fund Ticker CUSIP Global X Cannabis ETF POTX 37954Y145 Global X Carbon Credits Strategy ETF NTRL 37960A586 Global X China Biotech Innovation ETF CHB 37954Y251 Global X Green Building ETF GRNR 37960A842 Global X Health & Wellness ETF BFIT 3

    1/19/24 4:37:00 PM ET
    $BFIT
    $CHB
    $CHIC

    Global X ETFs Announces ETF Reverse Stock Split of POTX

    NEW YORK, May 20, 2022 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced a reverse split of the Global X Cannabis ETF (POTX) ("the Fund"). Effective after market close on June 10, 2022, the Fund will affect a reverse split at a ratio of 1:6. The reverse split will increase the price per share of the Fund with a proportionate decrease in the number of shares outstanding. For example, every six pre-split shares will result in receipt of one post-split share, which will be priced six times higher than the net asset value (NAV) of a pre-split share. Illustration of Reverse Split The following table shows the effect of a hypothetical 1:6 r

    5/20/22 3:35:00 PM ET
    $POTX

    Avant Brands Reports Third Quarter Fiscal 2021 Financial Results

    KELOWNA, BC, Oct. 13, 2021 /CNW/ - Avant Brands Inc (TSX:AVNT) (OTCQX:AVTBF) (FRA: 1BUP) ("Avant" or the "Company"), a leading producer of high quality, handcrafted cannabis products, is pleased to announce its financial results for the third quarter of fiscal 2021 ended August 31, 2021 ("Q3 2021"). "We are excited to have posted two consecutive quarters of record revenues," said Norton Singhavon, Founder and CEO of Avant. "The Company has achieved positive momentum across three distinct channels: recreational, medical and export. In addition, the recent licensing of our 3PL

    10/13/21 11:09:00 PM ET
    $IMCC
    $POTX
    Medicinal Chemicals and Botanical Products
    Health Care

    Avant Brands Joins NASDAQ-Listed Cannabis ETF

    Kelowna, BC, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Avant Brands Inc (TSX:AVNT) (OTCQX:AVTBF) (FRA: 1BUP) ("Avant"), a leading producer of handcrafted, high quality cannabis products, announces that it has been added to the Global X Cannabis ETF (NASDAQ:POTX), which is listed on the NASDAQ exchange."Our recent efforts to expand our investor base by rebranding with concurrent dual graduations to the Toronto Stock Exchange and OTCQX have resulted in Avant gaining institutional exposure," said Norton Singhavon, Founder and CEO of Avant Brands. "Our inclusion in the Global X Cannabis ETF will provide us with the opportunity to continue expanding our exposure to investors and institutions across Nor

    8/24/21 8:30:00 AM ET
    $POTX

    Global X Cannabis ETF Financials

    Live finance-specific insights

    View All

    Global X ETFs Announces ETF Reverse Stock Split of POTX

    NEW YORK, May 20, 2022 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced a reverse split of the Global X Cannabis ETF (POTX) ("the Fund"). Effective after market close on June 10, 2022, the Fund will affect a reverse split at a ratio of 1:6. The reverse split will increase the price per share of the Fund with a proportionate decrease in the number of shares outstanding. For example, every six pre-split shares will result in receipt of one post-split share, which will be priced six times higher than the net asset value (NAV) of a pre-split share. Illustration of Reverse Split The following table shows the effect of a hypothetical 1:6 r

    5/20/22 3:35:00 PM ET
    $POTX

    Avant Brands Reports Third Quarter Fiscal 2021 Financial Results

    KELOWNA, BC, Oct. 13, 2021 /CNW/ - Avant Brands Inc (TSX:AVNT) (OTCQX:AVTBF) (FRA: 1BUP) ("Avant" or the "Company"), a leading producer of high quality, handcrafted cannabis products, is pleased to announce its financial results for the third quarter of fiscal 2021 ended August 31, 2021 ("Q3 2021"). "We are excited to have posted two consecutive quarters of record revenues," said Norton Singhavon, Founder and CEO of Avant. "The Company has achieved positive momentum across three distinct channels: recreational, medical and export. In addition, the recent licensing of our 3PL

    10/13/21 11:09:00 PM ET
    $IMCC
    $POTX
    Medicinal Chemicals and Botanical Products
    Health Care